Dejaco C, Matteson E L, Buttgereit F
Klinische Abteilung für Rheumatologie, Medizinische Universität Graz, Graz, Österreich.
Division of Rheumatology and Division of Epidemiology, Departments of Internal Medicine and Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
Z Rheumatol. 2016 Sep;75(7):687-700. doi: 10.1007/s00393-016-0105-3.
Polymyalgia rheumatica (PMR) is the most common autoimmune inflammatory disease in older persons with an average age of onset of 73 years. Typical symptoms include acute or subacute bilateral shoulder pain with severe stiffness and often neck and bilateral hip pain. Giant cell arteritis (GCA) occurs in approximately 20 % of cases and up to two thirds of patients with GCA have symptoms of PMR. There are many disease which mimic PMR, elderly onset rheumatoid arthritis is frequently misdiagnosed as PMR. Although there are no specific laboratory tests, C‑reactive protein and erythrocyte sedimentation rates are elevated in over 90 % of patients. The diagnosis may be aided by imaging, especially ultrasonography and magnetic resonance imaging (MRI). Treatment currently consists of glucocorticoids at an initial dose of 12.5-25 mg prednisone equivalent daily. Treatment duration is typically 2‑3 years but may be longer. Under certain conditions low-dose methotrexate can be used as adjuvant therapy.
风湿性多肌痛(PMR)是老年人中最常见的自身免疫性炎症性疾病,平均发病年龄为73岁。典型症状包括急性或亚急性双侧肩部疼痛伴严重僵硬,常伴有颈部和双侧髋部疼痛。巨细胞动脉炎(GCA)约在20%的病例中出现,高达三分之二的GCA患者有PMR症状。有许多疾病可模仿PMR,老年起病的类风湿关节炎常被误诊为PMR。虽然没有特异性实验室检查,但超过90%的患者C反应蛋白和红细胞沉降率升高。影像学检查,尤其是超声和磁共振成像(MRI)有助于诊断。目前的治疗包括初始剂量为每日12.5 - 25毫克泼尼松等效剂量的糖皮质激素。治疗持续时间通常为2 - 3年,但可能更长。在某些情况下,低剂量甲氨蝶呤可作为辅助治疗。